TIMD4 and neoplasm: The scarcity of KCs in the tumor periphery was further confirmed using antibody labeling of F4/80, TIM4, and CRIg, clearly showing a “dark zone” surrounding hepatic macrometastases (Figure 3, E and F, and Supplemental Figure 10A).